...
首页> 外文期刊>Pipeline & gas journal >Exxon Outlook To 2040 Predicts Little Impact For Renewables, Cost On Carbon To Benefit Natural Gas
【24h】

Exxon Outlook To 2040 Predicts Little Impact For Renewables, Cost On Carbon To Benefit Natural Gas

机译:埃克森美孚的2040年展望预测,可再生能源的影响不大,碳成本将使天然气受益

获取原文
获取原文并翻译 | 示例
           

摘要

ExxonMobil's report "The Outlook for Energy: A View to 2040," released at a press conference with executives last spring, predicts world energy demand rising by 35% over the next 30 years, mostly due to increasing demand in Asia and population growth worldwide. With global electricity generation demand up 85% over 2010 to 117 quadrillion Btus in 2040, the company forecast that a cost on carbon emissions in the United States, at minimum, would make natural gas the most economical fuel for electricity for much of the period, beating out both coal and nuclear energy. Bill Colton, vice president of strategic planning at ExxonMobil, laid out forecasts in efficiency gains for the U.S. population that would take emissions per capita down by half, despite population growth leading to roughly equal energy use on a nationwide level between now and 2040. Transportation fuel was a big source of efficiency gains due to rising national standards. "Around the world most of this is actually being driven by government policy. Consumers naturally do seek more efficiency when they buy cars, but they do not seek this level of efficiency. Consumers might not make those same choices," Colton explained.
机译:埃克森美孚(ExxonMobil)在去年春季与高管们举行的新闻发布会上发布的报告《能源展望:2040年的展望》预测,未来30年世界能源需求将增长35%,这主要是由于亚洲需求的增长和全球人口的增长。到2040年,全球发电需求将比2010年增长85%,达到117万亿Btus,该公司预测,在美国,碳排放成本至少将使这段时期的天然气成为最经济的电力燃料,击败煤炭和核能。埃克森美孚公司战略规划副总裁比尔·科尔顿(Bill Colton)提出了美国人口效率提高的预测,尽管从现在到2040年,人口增长将导致全国范围内的能源使用大致相等,但人均排放量将减少一半。由于国家标准的提高,燃料是提高效率的重要来源。科尔顿解释说:“全世界大多数情况实际上是由政府政策驱动的。消费者在购买汽车时自然会寻求更高的效率,但他们并没有寻求这种效率水平。消费者可能不会做出相同的选择。”

著录项

  • 来源
    《Pipeline & gas journal》 |2013年第7期|143-143|共1页
  • 作者

    Erin Nelsen Parekh;

  • 作者单位
  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号